UA84024C2 - Новые вакцинные композиции, которые содержат эмульсию типа "масло в воде" - Google Patents
Новые вакцинные композиции, которые содержат эмульсию типа "масло в воде"Info
- Publication number
- UA84024C2 UA84024C2 UAA200601926A UAA200601926A UA84024C2 UA 84024 C2 UA84024 C2 UA 84024C2 UA A200601926 A UAA200601926 A UA A200601926A UA A200601926 A UAA200601926 A UA A200601926A UA 84024 C2 UA84024 C2 UA 84024C2
- Authority
- UA
- Ukraine
- Prior art keywords
- immunogen
- emulsion
- oil
- inactivated
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Данное изобретение касается вакцинной композиции, которая содержит эмульсию типа "масло в воде", которая имеет повышенную стабильность в присутствии бактериальных или вирусных суспензий, особенно концентрированных и неочищенных или слабоочищенных суспензий, где указанная эмульсия содержит водный раствор, который содержит иммуноген; минеральное масло; неионный липофильный детергент; неионный гидрофильный детергент с низким значением гидрофильно-липофильного баланса (HLB), больше 9 и меньше 13; и неионный гидрофильный детергент с высоким значением HLB, больше 13 и меньше 40.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49034503P | 2003-07-24 | 2003-07-24 | |
PCT/US2004/024027 WO2005009462A2 (en) | 2003-07-24 | 2004-07-26 | Vaccine formulations comprising an oil-in-water emulsion |
Publications (1)
Publication Number | Publication Date |
---|---|
UA84024C2 true UA84024C2 (ru) | 2008-09-10 |
Family
ID=34102977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200601926A UA84024C2 (ru) | 2003-07-24 | 2004-07-26 | Новые вакцинные композиции, которые содержат эмульсию типа "масло в воде" |
Country Status (23)
Country | Link |
---|---|
US (3) | US7371395B2 (ru) |
EP (1) | EP1651265B1 (ru) |
JP (1) | JP2006528647A (ru) |
KR (1) | KR101146545B1 (ru) |
CN (1) | CN1852735B (ru) |
AT (1) | ATE392905T1 (ru) |
AU (1) | AU2004259034C1 (ru) |
BR (1) | BRPI0412855B8 (ru) |
CA (1) | CA2533581C (ru) |
CY (1) | CY1108782T1 (ru) |
DE (1) | DE602004013331T2 (ru) |
DK (1) | DK1651265T3 (ru) |
ES (1) | ES2307053T3 (ru) |
HK (1) | HK1083764A1 (ru) |
HR (1) | HRP20080235T3 (ru) |
MX (1) | MXPA06000942A (ru) |
NZ (1) | NZ545289A (ru) |
PL (1) | PL1651265T3 (ru) |
RU (1) | RU2354399C2 (ru) |
SI (1) | SI1651265T1 (ru) |
UA (1) | UA84024C2 (ru) |
WO (1) | WO2005009462A2 (ru) |
ZA (1) | ZA200600937B (ru) |
Families Citing this family (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8088388B2 (en) * | 2002-02-14 | 2012-01-03 | United Biomedical, Inc. | Stabilized synthetic immunogen delivery system |
RU2354399C2 (ru) * | 2003-07-24 | 2009-05-10 | Мериал Лимитед | Вакцинная композиция и способ индуцирования иммунологического ответа у животного |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
HUE025537T2 (en) * | 2004-12-30 | 2016-05-30 | Boehringer Ingelheim Vetmedica Inc | PCV2-immunogenic compositions and methods for preparing such compositions |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
US8703095B2 (en) | 2005-07-07 | 2014-04-22 | Sanofi Pasteur S.A. | Immuno-adjuvant emulsion |
WO2007051329A1 (de) * | 2005-11-02 | 2007-05-10 | Laboswiss Ag | Verfahren zum extrahieren und solubilisieren von wirkstoffen aus organischem material, nach dem verfahren hergestellte wirkstoff-erzeuignisse und ihre verwendung |
US11707520B2 (en) | 2005-11-03 | 2023-07-25 | Seqirus UK Limited | Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
EA014028B1 (ru) * | 2005-11-04 | 2010-08-30 | Новартис Вэксинс Энд Диагностикс Срл | Эмульсии, содержащие свободное поверхностно-активное вещество в водной фазе в качестве адъюванта сплит вакцин против гриппа |
DK2368572T3 (da) | 2005-11-04 | 2020-05-25 | Seqirus Uk Ltd | Adjuvansvacciner med ikke-virionantigener fremstillet fra influenza-virusser dyrket i cellekultur |
AU2006321364B2 (en) * | 2005-12-01 | 2011-11-10 | Domantis Limited | Noncompetitive domain antibody formats that bind Interleukin 1 Receptor type 1 |
JP5739602B2 (ja) | 2005-12-29 | 2015-06-24 | ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド | ブタの臨床症状の緩和のためのpcv2免疫原性組成物の使用 |
BRPI0620859A2 (pt) * | 2005-12-29 | 2011-11-22 | Boehringer Ingelheim Vetmedica, Inc. | vacina de combinação multivalente contra pcv2 |
FR2896162B1 (fr) * | 2006-01-13 | 2008-02-15 | Sanofi Pasteur Sa | Emulsion huile dans eau thermoreversible |
US20090038701A1 (en) | 2006-01-17 | 2009-02-12 | Baxter International Inc. | Device, system and method for mixing |
EP1991262A4 (en) * | 2006-03-03 | 2009-11-04 | Merial Ltd | MYCOPLASMA HYOPNEUMONIAE VACCINE |
EP3167900B1 (en) | 2006-03-29 | 2018-11-21 | Merial Limited | Vaccine against streptococci |
US9839685B2 (en) * | 2006-04-13 | 2017-12-12 | The Regents Of The University Of Michigan | Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen |
US10138279B2 (en) | 2006-04-13 | 2018-11-27 | Regents Of The University Of Michigan | Compositions and methods for Bacillus anthracis vaccination |
US20080107687A1 (en) * | 2006-11-06 | 2008-05-08 | Herve Poulet | Feline vaccines against avian influenza |
KR100904226B1 (ko) * | 2006-11-08 | 2009-06-25 | (주)인터리스 | 레시틴 유사유화제를 함유하는 나노좀 형태의 면역증강제및 그의 백신용 조성물 |
EP2099927A4 (en) * | 2006-11-22 | 2010-05-05 | Boehringer Ingelheim Vetmed | METHODS FOR REDUCING FLAMBEES OF DISEASES ASSOCIATED WITH PORCINIC CIRCOVIRUS |
EP2859900A1 (en) * | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
UA100370C2 (uk) | 2006-12-11 | 2012-12-25 | Мериал Лимитед | Спосіб вакцинації птахів проти salmonella |
HUE033130T2 (en) | 2006-12-15 | 2017-11-28 | Boehringer Ingelheim Vetmedica Inc | Treatment of seropositive pigs with anti-PCV2 antibody with PCV2 antigen |
EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
US8003073B2 (en) * | 2007-04-16 | 2011-08-23 | Air Products And Chemicals, Inc. | Autothermal hydrogen storage and delivery systems |
US20090017064A1 (en) * | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
BRPI0821456A2 (pt) * | 2007-12-31 | 2015-06-16 | Boehring Ingelheim Vetmedica Inc | Partícula similar à pcv2 orf2 com inserção de aminoácido estranho |
BRPI0907438A2 (pt) * | 2008-01-23 | 2015-08-04 | Boehringer Ingelheim Vetmed | Composições imunogênicas para mycoplasma hyopneumoniae e pcv2 e métodos para produzir tais composições |
EP2254595A4 (en) * | 2008-02-15 | 2012-12-05 | Boehringer Ingelheim Vetmed | METHODS AND COMPOSITIONS FOR REDUCING THE IMPACT OF ENTERIC DISEASES |
EP2293813A4 (en) | 2008-05-23 | 2012-07-11 | Univ Michigan | NANOEMULSION VACCINES |
EP3168307B1 (en) | 2008-11-28 | 2020-07-15 | Boehringer Ingelheim Animal Health USA Inc. | Recombinant avian influenza vaccine and uses thereof |
JP5642712B2 (ja) | 2009-02-10 | 2014-12-17 | ノバルティス アーゲー | 少ない量のスクアレンを含むインフルエンザワクチン |
CN102428099B (zh) | 2009-04-03 | 2016-03-16 | 梅里亚有限公司 | 运载新城疫病毒的禽疫苗 |
ES2566646T3 (es) * | 2009-06-16 | 2016-04-14 | The Regents Of The University Of Michigan | Vacunas en nanoemulsión |
PT3210622T (pt) | 2009-08-21 | 2021-03-03 | Univ Georgia | Vacina recombinante contra o paramixovírus aviário e método de preparação e utilização da mesma |
TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物 |
HUE030664T2 (en) * | 2009-09-10 | 2017-05-29 | Merial Inc | New vaccine formulations containing saponin-containing adjuvant |
MX351643B (es) | 2009-12-28 | 2017-10-23 | Merial Ltd | Antigeno ndv recombinante y usos del mismo. |
FR2955775B1 (fr) * | 2010-02-01 | 2012-05-04 | Seppic Sa | Adjuvant pour la preparation de compositions vaccinales destinees a la prevention contre les coccidioses |
FR2955776A1 (fr) * | 2010-02-01 | 2011-08-05 | Seppic Sa | Utilisation d'une huile minerale specifique pour la fabrication d'un nouveau adjuvant |
US20130197612A1 (en) | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
US9345759B2 (en) | 2010-03-12 | 2016-05-24 | Merial, Inc. | Bluetongue virus recombinant vaccines and uses thereof |
FR2957803B1 (fr) * | 2010-03-24 | 2012-06-01 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Diluants adjuvants de vaccins vivants pour maladies porcines |
FR2957933B1 (fr) * | 2010-03-24 | 2012-04-27 | Seppic Sa | Vaccin vivant pour maladies aviaires |
EP2569007B1 (en) | 2010-05-11 | 2015-10-14 | Intervet International B.V. | Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies |
KR101675185B1 (ko) * | 2010-07-08 | 2016-11-10 | 유나이티드 바이오메디칼 인크. | 디자이너(designer) 펩티드-기반 pcv2 백신 |
WO2012030720A1 (en) | 2010-08-31 | 2012-03-08 | Merial Limited | Newcastle disease virus vectored herpesvirus vaccines |
DK3156056T3 (da) * | 2011-03-18 | 2024-02-26 | Alkermes Pharma Ireland Ltd | Farmaceutiske sammensætninger der består af sorbitanestere |
AU2012245395A1 (en) | 2011-04-20 | 2013-11-14 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
ES2764079T3 (es) | 2011-05-27 | 2020-06-02 | Boehringer Ingelheim Animal Health Usa Inc | Vacunas genéticas contra el virus Hendra y el virus Nipah |
EP2714077B1 (en) * | 2011-06-01 | 2018-02-28 | Merial, Inc. | Needle-free administration of prrsv vaccines |
CN103182076B (zh) * | 2011-12-29 | 2015-06-17 | 北京大北农科技集团股份有限公司 | 一种猪支原体肺炎灭活疫苗及其制备方法 |
US20130177591A1 (en) * | 2012-01-10 | 2013-07-11 | Merial Limited | Lipid Based Adjuvants for DNA Plasmids |
SI2814508T1 (sl) * | 2012-02-14 | 2017-10-30 | Merial, Inc. | Rotavirusna podenotska cepiva ter postopki njihove izdelave in uporaba |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
CA2867121C (en) | 2012-03-19 | 2021-05-25 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising fatty acid esters |
ES2950418T3 (es) | 2012-03-19 | 2023-10-09 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas que comprenden alcohol bencílico |
JP6219918B2 (ja) | 2012-03-19 | 2017-10-25 | アルカームス ファーマ アイルランド リミテッド | グリセロールエステルを含む医薬組成物 |
UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
US10801039B2 (en) | 2012-06-13 | 2020-10-13 | The University Court Of The University Of Glasgow | Reassortant BTV and AHSV vaccines |
WO2014039978A2 (en) | 2012-09-10 | 2014-03-13 | Szathmary Dr Susan | Vaccine to prevent mycoplasmal infection in waterfowl |
CN102813922B (zh) * | 2012-09-11 | 2013-12-11 | 山东省农业科学院畜牧兽医研究所 | 一种复方油佐剂及其制备方法和应用 |
NZ730571A (en) | 2012-09-19 | 2018-12-21 | Alkermes Pharma Ireland Ltd | Pharmaceutical compositions having improved storage stability |
JP2016507225A (ja) | 2012-12-18 | 2016-03-10 | メリアル インコーポレイテッド | Ibv、csfv及びndvの高解像度融解遺伝子型決定 |
CN103059134B (zh) * | 2013-01-18 | 2015-03-04 | 武汉辉斯特科技有限公司 | 一种抗结核多肽的免疫制备方法 |
BR102013001893B1 (pt) | 2013-01-25 | 2022-01-25 | Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig | Antígenos recombinantes do porcine circovirus 2 (pcv-2) para formulações vacinais, kit de diagnóstico e uso |
US9556419B2 (en) | 2013-03-12 | 2017-01-31 | Merial Inc. | Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof |
EP2789346A1 (en) * | 2013-04-11 | 2014-10-15 | CEVA Santé Animale SA | Fusion polypeptides and vaccines |
EP2994162B1 (en) | 2013-05-08 | 2021-04-07 | Pharmgate Biologics Inc. | Vaccine for pcv2 and mycoplasma |
EA035265B1 (ru) | 2013-10-02 | 2020-05-21 | Бёрингер Ингельхайм Энимал Хелс Ю-Эс-Эй Инк. | Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы |
FR3012964A1 (fr) * | 2013-11-12 | 2015-05-15 | Seppic Sa | Vaccins adjuves pour vaccination aviaire in ovo |
US10801070B2 (en) | 2013-11-25 | 2020-10-13 | The Broad Institute, Inc. | Compositions and methods for diagnosing, evaluating and treating cancer |
CN103585622B (zh) * | 2013-11-25 | 2015-09-02 | 江苏省农业科学院 | 猪支原体肺炎疫苗株的应用 |
JP6488304B2 (ja) | 2013-12-03 | 2019-03-20 | インターベット インターナショナル ベー. フェー. | ローソニア・イントラセルラリス(lawsonia intracellularis)及びブタサーコウイルス(porcine circovirus)2に対するワクチン |
DK3076996T3 (en) | 2013-12-03 | 2020-03-09 | Intervet Int Bv | Vaccine mod porcint circovirus type 2 |
WO2015085147A1 (en) | 2013-12-05 | 2015-06-11 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
CA2934073A1 (en) | 2013-12-20 | 2015-06-25 | The Broad Institute, Inc. | Combination therapy with neoantigen vaccine |
MX2016012041A (es) | 2014-03-20 | 2017-01-19 | Alkermes Pharma Ireland Ltd | Formulaciones de aripiprazol que tienen mayores velocidades de inyeccion. |
WO2015179412A1 (en) | 2014-05-19 | 2015-11-26 | Merial, Inc. | Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (pedv) |
WO2016073410A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
EP3757211A1 (en) | 2014-12-19 | 2020-12-30 | The Broad Institute, Inc. | Methods for profiling the t-cell-receptor repertoire |
US10975442B2 (en) | 2014-12-19 | 2021-04-13 | Massachusetts Institute Of Technology | Molecular biomarkers for cancer immunotherapy |
WO2016183423A1 (en) | 2015-05-14 | 2016-11-17 | Merial Inc. | Method for porcine circovirus production and pcv2 vaccines |
IL302102A (en) | 2015-05-20 | 2023-06-01 | Dana Farber Cancer Inst Inc | shared neoantigens |
TW202241500A (zh) | 2015-06-09 | 2022-11-01 | 美商博德研究所有限公司 | 用於贅瘤疫苗之調配物及其製備方法 |
MX2017016895A (es) | 2015-06-23 | 2018-04-10 | Merial Inc | Vectores virales recombinantes que contienen la proteina menor del virus del sindrome reproductor y respiratorio porcino (prrsv) y sus metodos de elaboracion y uso. |
EP3313440A2 (en) | 2015-06-26 | 2018-05-02 | Merial, Inc. | Inactivated canine influenza vaccines and methods of making and uses thereof |
EP3355915B1 (en) | 2015-09-29 | 2023-11-01 | Boehringer Ingelheim Animal Health USA Inc. | Canine parvovirus (cpv) virus-like particle (vlp) vaccines and uses thereof |
MX2018004221A (es) | 2015-10-08 | 2019-11-08 | Pasteur Institut | Vacuna heterologa atenuada viva para leptospira. |
US10780158B2 (en) | 2015-11-16 | 2020-09-22 | Georgia State University Research Foundation, Inc. | Tunable vaccine platform against pathogens of the paramyxovirus family |
MA49414A (fr) | 2015-11-23 | 2020-04-22 | Boehringer Ingelheim Animal Health Usa Inc | Protéines de fusion de dmdv et e2 et leurs utilisations |
TWI760322B (zh) | 2016-01-29 | 2022-04-11 | 美商百靈佳殷格翰動物保健美國有限公司 | 重組腺病毒載體裝載之fmdv疫苗及其用途 |
CN108697782A (zh) * | 2016-03-23 | 2018-10-23 | 英特维特国际股份有限公司 | 针对pcv2病毒和猪肺炎支原体感染的组合疫苗 |
RU2746127C2 (ru) * | 2016-03-23 | 2021-04-07 | Интервет Интернэшнл Б.В. | Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs |
EP3439690A2 (en) | 2016-04-07 | 2019-02-13 | Merial, Inc. | Heartworm vaccine, methods and uses thereof |
CN109310776B (zh) * | 2016-04-14 | 2022-02-11 | 勃林格殷格翰动物保健美国公司 | 含有抗微生物的聚酰胺或奥替尼啶防腐剂的多次剂量组合物 |
US20190346442A1 (en) | 2016-04-18 | 2019-11-14 | The Broad Institute, Inc. | Improved hla epitope prediction |
US10279031B2 (en) * | 2016-05-11 | 2019-05-07 | Phibro Animal Health Corporation | Composition comprising antigens and a mucosal adjuvant and a method for using |
JP7018941B2 (ja) | 2016-06-17 | 2022-02-14 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | 直鎖または分枝ポリアクリル酸ポリマーアジュバントを含む新規な免疫原性処方物 |
JOP20190088A1 (ar) | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
WO2018099889A1 (en) * | 2016-11-29 | 2018-06-07 | Intervet International B.V. | Swine vaccine |
MA49874A (fr) | 2016-12-14 | 2020-06-24 | Boehringer Ingelheim Animal Health Usa Inc | Vecteurs hvt recombinants exprimant de multiples antigènes de pathogènes aviaires, et vaccins les contenant |
EP3574116A1 (en) | 2017-01-24 | 2019-12-04 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
CA3092335A1 (en) | 2018-03-05 | 2019-09-12 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
CN108324941A (zh) * | 2018-04-03 | 2018-07-27 | 林淑卿 | 猪疾病疫苗用佐剂及其制备方法 |
WO2020072700A1 (en) | 2018-10-02 | 2020-04-09 | Dana-Farber Cancer Institute, Inc. | Hla single allele lines |
WO2020131586A2 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Methods for identifying neoantigens |
WO2022136952A1 (en) | 2020-12-23 | 2022-06-30 | Infectious Disease Research Institute | Solanesol vaccine adjuvants and methods of preparing same |
WO2024133656A1 (en) | 2022-12-22 | 2024-06-27 | Ceva Sante Animale | Oil adjuvant compositions and vaccine emulsions comprising such oil adjuvant compositions |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1143545A (en) * | 1965-03-25 | 1969-02-26 | Wellcome Found | Injectable vaccine emulsions |
PH30906A (en) * | 1991-07-25 | 1997-12-23 | Idec Pharma Corp | Induction of cytotoxic t-lymphocyte responses. |
JPH10218788A (ja) * | 1997-02-07 | 1998-08-18 | Natl Fedelation Of Agricult Coop Assoc | 免疫増強剤の製造法および免疫増強法 |
US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
AU755445B2 (en) | 1998-05-07 | 2002-12-12 | Corixa Corporation | Adjuvant composition and methods for its use |
CA2440933A1 (en) * | 1998-12-22 | 2000-06-22 | Pfizer Products Inc. | An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
US6943152B1 (en) * | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
FR2800280B1 (fr) * | 1999-10-29 | 2003-09-19 | Seppic Sa | Nouvelle composition vaccinale et utilisation d'agents tensioactifs comme adjuvants d'immunite |
DE10012370A1 (de) * | 2000-03-14 | 2001-09-27 | Chiron Behring Gmbh & Co | Adjuvans für Vakzinen |
GB0009735D0 (en) * | 2000-04-19 | 2000-06-07 | Zeneca Ltd | Formulation |
DE10113284A1 (de) * | 2001-03-16 | 2002-10-02 | Heinrich Exner | Adjuvans-Emulsion und Verfahren zu deren Verwendung |
FR2824269B1 (fr) * | 2001-09-03 | 2012-03-02 | Seppic Sa | Composition adjuvante constituee de 1% a 15% de tensioactifs a hlb global compris entre 5 et 8 et de 85% a 99% de corps gras |
US6642178B2 (en) * | 2001-11-14 | 2003-11-04 | North Dakota State University | Adjuvant blend for enhancing efficacy of pesticides |
RU2354399C2 (ru) * | 2003-07-24 | 2009-05-10 | Мериал Лимитед | Вакцинная композиция и способ индуцирования иммунологического ответа у животного |
-
2004
- 2004-07-26 RU RU2006105506/13A patent/RU2354399C2/ru active
- 2004-07-26 UA UAA200601926A patent/UA84024C2/ru unknown
- 2004-07-26 CA CA2533581A patent/CA2533581C/en not_active Expired - Lifetime
- 2004-07-26 SI SI200430782T patent/SI1651265T1/sl unknown
- 2004-07-26 AU AU2004259034A patent/AU2004259034C1/en not_active Expired
- 2004-07-26 ES ES04779201T patent/ES2307053T3/es not_active Expired - Lifetime
- 2004-07-26 WO PCT/US2004/024027 patent/WO2005009462A2/en active Application Filing
- 2004-07-26 US US10/899,181 patent/US7371395B2/en active Active
- 2004-07-26 EP EP04779201A patent/EP1651265B1/en not_active Expired - Lifetime
- 2004-07-26 BR BRPI0412855A patent/BRPI0412855B8/pt active IP Right Grant
- 2004-07-26 PL PL04779201T patent/PL1651265T3/pl unknown
- 2004-07-26 KR KR1020067001685A patent/KR101146545B1/ko active IP Right Grant
- 2004-07-26 AT AT04779201T patent/ATE392905T1/de active
- 2004-07-26 DK DK04779201T patent/DK1651265T3/da active
- 2004-07-26 DE DE602004013331T patent/DE602004013331T2/de not_active Expired - Lifetime
- 2004-07-26 NZ NZ545289A patent/NZ545289A/en unknown
- 2004-07-26 MX MXPA06000942A patent/MXPA06000942A/es active IP Right Grant
- 2004-07-26 CN CN200480026569XA patent/CN1852735B/zh not_active Expired - Lifetime
- 2004-07-26 JP JP2006521308A patent/JP2006528647A/ja active Pending
-
2006
- 2006-02-01 ZA ZA200600937A patent/ZA200600937B/en unknown
- 2006-05-25 HK HK06106020A patent/HK1083764A1/xx not_active IP Right Cessation
-
2008
- 2008-02-07 US US12/027,776 patent/US7608279B2/en not_active Expired - Lifetime
- 2008-05-28 HR HR20080235T patent/HRP20080235T3/xx unknown
- 2008-07-17 CY CY20081100747T patent/CY1108782T1/el unknown
-
2009
- 2009-09-10 US US12/556,891 patent/US20100062019A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA84024C2 (ru) | Новые вакцинные композиции, которые содержат эмульсию типа "масло в воде" | |
AR078169A1 (es) | Formulaciones de vacunas que comprenden adyuvantes con saponina | |
BR0214919A (pt) | clones de dna infecciosos quiméricos, circovìrus suìno quiméricos e usos dos mesmos | |
BR9911870A (pt) | Vacina de parvovìrus e circovìrus de suìno | |
BR0204470A (pt) | Uso de flavivirus para a expressão de epitopos de proteìna e para o desenvolvimento de um novo virus vacinal vivo atenuado para imunização contra flavivirus e outros agentes infecciosos | |
AR024022A1 (es) | Un metodo para la estabilizacion de las composiciones suavizantes de telas | |
AR036039A1 (es) | Composicion de vacuna para el virus de la influenza | |
ME00009B (me) | Suspenzioni koncentrati na bazi ulja | |
PT1326635E (pt) | Composicao farmaceutica para imunizacao contra a sida | |
ES2153223T3 (es) | Flavivirus quimericos y/o flavivirus de crecimiento restringido. | |
CA2305623A1 (fr) | Circovirus porcins, vaccins et reactifs de diagnostic | |
DE59410380D1 (de) | Endosomolytisch wirksame partikel | |
AR075437A1 (es) | Composicion inmunogenica que comprende al menos un antigeno del virus del dengue inactivado y un adyuvante sin aluminio, metodo para producir dicha vacuna y su uso para preparar un medicamento | |
AR052162A1 (es) | Composiciones farmaceuticas inyectables estabilizadas con particulados de posaconazol | |
MA32030B1 (fr) | Vaccins anti-malaria | |
MY141874A (en) | Vaccine formulations comprising an oil-in-water emulsion | |
US20190105385A1 (en) | A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection | |
BR0112486A (pt) | Poliproteìna, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição farmacêutica, e, método para imunizar um indivìduo contra hiv | |
ES2643031T3 (es) | Vacuna contra garrapatas de Rhipicephalus | |
EP1167530A3 (en) | PVX capsid-antigen fusion protein, chimaeric viral particles displaying it on the capsid, plants infected with said particles, their uses and compositions comprising them | |
CY1116098T1 (el) | Χιμαιρικοι μολυσματικοι κλωνοι dna του κυκλοϊου των χοιρων και χρησεις εξ αυτων | |
MY145463A (en) | Flavivirus ns1 subunit vaccine |